LOG IN OR SIGN UP TO "MY Eu2P"UPCOMING CERTIFICATES
Our certificate courses take place within the master year 1 or year 2 curriculum schedule.
Therefore, some may be available for application, while others might be temporarily closed. In the latter case, please see the course details for the next application periods.
OPEN FOR APPLICATION
BASIC PHARMACOVIGILANCE AND PHARMACOVIGILANCE REGULATIONS
Let us guide you through the Basic Pharmacovigilance and Pharmacovigilance Regulations topics and get the necessary knowledge and skills to do it right
PHARMACOVIGILANCE FOR BIOLOGICS
Let us guide you through the Pharmacovigilance for Biologics topic and get the necessary knowledge and skills to do it right
EXTERNAL DATABASES - RWD - RWE
Let us guide you through the External databases/RWD/RWE topic and get the necessary knowledge and skills to do it right
BENEFIT RISK ASSESSMENT
Let us guide you through the Benefit Risk Assessment topic and get the necessary knowledge and skills to do it right
CLINICAL PHARMACOLOGY FOUNDATIONS FOR DRUG DEVELOPMENT
Recognise the main issues of Randomised Clinical Trials (RCT), their strengths and weaknesses
INTEGRATED CLINICAL AND TRANSLATIONAL PHARMACOLOGY
Be aware of the different sources of information used by physicians to prescribe medicines
GLOBAL PHARMACOVIGILANCE SYSTEMS AND DRUG SAFETY MANAGEMENT
Understand pharmacovigilance principles and stakeholders during medicines lifecycle
EU AND GLOBAL PHARMACOVIGILANCE REGULATORY FRAMEWORKS
Get familiar with the EU, US and major local and worldwide pharmacovigilance regulations and guidelines
SAFETY SIGNAL DETECTION AND ADVERSE EVENT MANAGEMENT
Get familiar with adverse drug reactions, safety signals and how to handle them
BENEFIT-RISK AND HEALTH ECONOMICS FOR STRATEGIC DECISION-MAKING
Understand the role of benefit-risk assessment and pharmacoeconomics in the process of decision-making on medicines by different stakeholders
APPLIED PHARMACOEPIDEMIOLOGY AND REAL-WORLD DATA ANALYSIS
Know the real use of a medicine as compared to the "theoretical" indication it was intended and studied for
QUANTITATIVE DRUG UTILISATION AND PRESCRIBING PATTERN ANALYSIS
Learn how to evaluate and design quantitative drug utilisation studies
EFFECTIVE COMMUNICATION OF BENEFIT-RISK INFORMATION
Get deeper in the medicines risk communication: stakeholders, media, regulations
CRITICAL APPRAISAL AND VALUE OF SCIENTIFIC EVIDENCE
Learn how to critically appraise scientific research and to valorise yours
APPLIED EPIDEMIOLOGY FOR REAL-WORLD EVIDENCE
Get familiar with epidemiology and its application to medicines surveillance
BIOSTATISTICS FOR DRUG DEVELOPMENT AND REGULATORY DECISION-MAKING
Get familiar with statistics and their use in epidemiological studies
CLINICAL RESEARCH METHODS AND REAL-WORLD EFFECTIVENESS ASSESSMENT
Learn how to design clinical trials and analyse clinical research
PHARMACOVIGILANCE PROCESSES, SUBMISSIONS AND INSPECTIONS
Understand the regulatory requirements and best practices for the Pharmaceutical Industry operational aspects of pharmacovigilance
HEALTH OUTCOMES AND ECONOMIC VALUATION OF HEALTH STATES
Learn how to evaluate quantitative benefit-risk assessment to help in the decision-making process on medicines
ADVANCED ANALYTICS FOR BENEFIT-RISK AND REGULATORY DECISIONS
Learn to evaluate (and design, for the extended version of this module) all relevant aspects of pharmacoeconomic evaluation studies.
QUALITATIVE METHODS IN DRUG UTILISATION AND HEALTHCARE RESEARCH
Learn how to evaluate and design qualitative drug utilisation studies
FOUNDATIONS OF RISK COMMUNICATION IN HEALTHCARE
Get introducted to the basics of communication and medicines risk communication
STAKEHOLDER ENGAGEMENT AND CRISIS COMMUNICATION IN DRUG SAFETY
Learn about strategies to address the main challenges of medicines risk communication
QUANTITATIVE RISK ASSESSMENT AND BENEFIT-RISK MODELING
Understand and assist in pharmacoepidemiological studies using large healthcare databases
CURRENTLY CLOSED FOR APPLICATION
Check the course details for the next application periods.
RISK FACTORS AND PATIENT SUSCEPTIBILITY TO ADVERSE DRUG REACTIONS
Learn pharmacogenetic successes and failures and be aware of potential limitations of pharmacogenetic results
QUANTITATIVE BENEFIT-RISK ANALYSIS AND DECISION MODELING
Get expert in quantitative benefit-assessment impact on different decision makers at different phases of drug development
